NCT05681975 Immunoglobulin G4 and Immunoglobulin E Antibodies in a Population With Adverse Reactions to Foodstuffs-related Symptoms
| NCT ID | NCT05681975 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Universidad Politecnica de Madrid |
| Condition | Immunoglobulin E-Mediated Food Allergy |
| Study Type | OBSERVATIONAL |
| Enrollment | 200 participants |
| Start Date | 2017-10-01 |
| Primary Completion | 2027-10 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 200 participants in total. It began in 2017-10-01 with a primary completion date of 2027-10.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of this study is to analyze a population with symptoms associated with adverse reactions to foodstuffs (ARFS). To determine the levels of food-specific immunoglobulin G4 (IgG4) and immunoglobulin E (IgE) antibody reactions (AbR).
Eligibility Criteria
Inclusion Criteria: * Adults (\>18 years of age) * To present symptoms related to adverse reactions to foodstuffs (ARFS) Exclusion Criteria: * Antibiotic treatment
Contact & Investigator
Lisset Pantoja-Arévalo, MSc
PRINCIPAL INVESTIGATOR
Universidad Politecnica de Madrid
Frequently Asked Questions
Who can join the NCT05681975 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 80 Years, studying Immunoglobulin E-Mediated Food Allergy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05681975 currently recruiting?
Yes, NCT05681975 is actively recruiting participants. Contact the research team at l.pantoja@upm.es for enrollment information.
Where is the NCT05681975 trial being conducted?
This trial is being conducted at Madrid, Spain.
Who is sponsoring the NCT05681975 clinical trial?
NCT05681975 is sponsored by Universidad Politecnica de Madrid. The principal investigator is Lisset Pantoja-Arévalo, MSc at Universidad Politecnica de Madrid. The trial plans to enroll 200 participants.